73102 Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 

Services (HHS) announces the following 

joint meeting of the Subcommittee on 

Privacy, Confidentiality, and Security 

and the Subcommittee on Standards, 

two subcommittees of the National 

Committee on Vital and Health 

Statistics. This meeting is open to the 

public. 

DATES: Thursday, September 19, 2024: 

11 a.m.–5 p.m. EDT and Friday, 

September 20, 2024: 10 a.m.–3 p.m. 

EDT. 

ADDRESSES: Virtual open meeting. The 

public is welcome to obtain the link to 

attend this meeting by following the 

instructions posted on the Committee 

website: https://ncvhs.hhs.gov/ 

meetings/full-committee-meeting-17/. 

FOR FURTHER INFORMATION CONTACT: 

Substantive program information may 

be obtained from Naomi Michaelis, 

MPA, Executive Secretary, NCVHS, 

National Center for Health Statistics, 

Centers for Disease Control and 

Prevention, 3311 Toledo Road, 

Hyattsville, Maryland 20782, or via 

electronic mail to nmichaelis@cdc.gov; 

or by telephone (301) 458–4202. 

Summaries of meetings and a roster of 

Committee members are available on the 

NCVHS website https://ncvhs.hhs.gov/, 

where further information including an 

agenda and instructions to access the 

broadcast of the meeting will be posted. 

Should you require reasonable 

accommodation, please telephone the 

CDC Office of Equal Employment 

Opportunity at (770) 488–3210 as soon 

as possible. 

SUPPLEMENTARY INFORMATION: As 

outlined in its Charter, the National 

Committee on Vital and Health 

Statistics assists and advises the 

Secretary of HHS on health data, data 

standards, statistics, privacy, national 

health information policy, and the 

Department’s strategy to best address 

those issues. The original authorities of 

NCVHS are described at 42 U.S. Code 

242k. Additional authorities were added 

by the Health Insurance Portability and 

Accountability Act of 1996 (HIPAA, 

Pub. L. 104–191, 110 Stat. 1936, Aug. 

21, 1996), under which NCVHS advises 

the Secretary on administrative 

simplification standards, including 

those for privacy, security, adoption and 

implementation of transaction 

standards, unique identifiers, code sets, 

and operating rules adopted under the 

Patient Protection and Affordable Care 

Act (ACA, Pub. L. 111–148, 124 Stat, 

119, Mar. 23, 2010). Included in HIPAA 

is the statutory reporting requirement 

that the Committee submit to Congress 

and make public, a report regarding the 

implementation of part C of title XI of 

the Social Security Act. 

Purpose: The purpose of the Joint 

Meeting of the Subcommittee on 

Privacy, Confidentiality and Security 

and the Subcommittee on Standards is 

to gather information and plan for 

upcoming projects. There will be a 

panel on privacy and security in health 

data access with invited experts. The 

agenda will also include updates from 

the Department, an update on the 

ongoing work of the ICD–11 Workgroup, 

and preparation for the upcoming work 

of the Subcommittee on Standards and 

a celebration of the 75th anniversary of 

the Committee. 

The Committee will reserve time on 

the agenda for public comment. Meeting 

times and topics are subject to change. 

Please refer to the agenda posted on the 

NCVHS website for updates: https://

ncvhs.hhs.gov/meetings/full-committeemeeting-17/. 

Sarah Lessem, 

Executive Director, NCVHS, Senior Data 

Policy Analyst, Office of Science and Data 

Policy, Office of the Assistant Secretary for 

Planning and Evaluation. 

[FR Doc. 2024–20232 Filed 9–6–24; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse, Initial Review Group; Career 

Development Education and Training Study 

Section. 

Date: October 24–25, 2024. 

Time: 9:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sindhu Kizhakke 

Madathil, Ph.D., Scientific Review Officer, 

Division of Extramural Research, Scientific 

Review Branch, National Institute on Drug 

Abuse, NIH, 301 North Stonestreet Avenue, 

MSC 6021, Bethesda, MD 20892, (301) 827– 

5702, sindhu.kizhakkemadathil@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Transformative Research on the Basic 

Mechanisms of Polysubstance Use in 

Addiction. 

Date: November 1, 2024. 

Time: 9:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Sindhu Kizhakke 

Madathil, Ph.D., Scientific Review Officer, 

Division of Extramural Research, Scientific 

Review Branch, National Institute on Drug 

Abuse, NIH, 301 North Stonestreet Avenue, 

MSC 6021, Bethesda, MD 20892, (301) 827– 

5702, sindhu.kizhakkemadathil@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Addressing HIV in Highest Risk Sexual and 

Gender Minorities. 

Date: November 4, 2024. 

Time: 12:30 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Shareen Amina Iqbal, 

Ph.D., Scientific Review Officer, Division of 

Extramural Research, Scientific Review 

Branch, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 443–4577, 

shareen.iqbal@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Functional Validation and/or 

Characterization of Genes or Variants 

Implicated in Substance Use Disorders and 

NIDA Animal Genomics Program. 

Date: November 19, 2024. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Health, 

National Institute on Drug Abuse, 301 North 

Stonestreet Avenue, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Devon Rene Oskvig, Ph.D., 

Scientific Review Officer, Division of 

Extramural Research, Scientific Review 

Branch, National Institute on Drug Abuse, 

NIH, 301 North Stonestreet Avenue, MSC 

6021, Bethesda, MD 20892, (301) 402–6965, 

devon.oskvig@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 174 / Monday, September 9, 2024 / Notices 73103 

Dated: September 4, 2024 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–20268 Filed 9–6–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Fiscal Year (FY) 2024 Notice of 

Supplemental Funding Opportunity 

AGENCY: Substance Abuse and Mental 

Health Services Administration, 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of intent to award 

supplemental funding. 

SUMMARY: This notice is to inform the 

public that the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) is supporting administrative 

supplements in scope of the parent 

award for the 59-eligible Community 

Mental Health Services Block Grant 

(MHBG) recipients funded under the 

FFY 2024–2025 Combined Block Grant 

Application (OMB Control Number 

0930–0168). The distribution of MHBG 

funds, including funds allocated for 

technical assistance, must adhere to a 

statutory formula. The formula 

considers the population at risk, the cost 

of providing services, and other relevant 

factors. To comply with these 

requirements, technical assistance funds 

will be distributed to States and 

territories using this established 

formula. These awards have a project 

end date of September 30, 2025. 

FOR FURTHER INFORMATION CONTACT: 

Asha Stanly, MHBG Program 

Coordinator, Substance Abuse and 

Mental Health Services Administration, 

5600 Fishers Lane, Rockville, MD 

20857, telephone (240) 276–1845; email: 

Asha.Stanly@samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Funding Opportunity Title: FY 2024 

Community Mental Health Services 

Block Grant OMB No. 0930–0168. 

Assistance Listing Number: 93.958. 

Authority: Sections 1911–1920 of title 

XIX, part B, subpart I of the Public 

Health Service Act (42 U.S.C. 300x300x-9) and sections 1941–1956 of title 

XIX, part B, subpart III of the Public 

Health Service Act (42 U.S.C. 300x–51– 

66). 

Justification: Eligibility for this 

supplemental funding is limited to the 

59 MHBG recipients of MHBG funding 

under the FFY 2024–2025 Combined 

Block Grant Application (OMB Control 

Number 0930–0168). 

This is not a formal request for 

application. Assistance will only be 

provided to the 59 MHBG recipients 

based on the receipt of a written 

statement from the MHBG recipients, 

confirming their interest in receiving 

these funds. 

Dated: September 3, 2024. 

Savannah Kidd, 

Public Health Analyst. 

[FR Doc. 2024–20184 Filed 9–6–24; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Fiscal Year (FY) 2024 Notice of 

Supplemental Funding Opportunity 

AGENCY: Substance Abuse and Mental 

Health Services Administration, 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of intent to award 

supplemental funding. 

SUMMARY: This notice is to inform the 

public that the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) is supporting administrative 

supplements in scope of the parent 

award for the 56 eligible grant recipients 

funded in FY 2024 Projects for 

Assistance in Transition from 

Homelessness Grant (PATH), Notice of 

Funding Opportunity (NOFO) SM–24– 

F2. Each PATH recipient may receive 

up to $8,967. These awards have a 

project end date of September 29, 2025. 

FOR FURTHER INFORMATION CONTACT: 

Dorrine Gross, PATH Program 

Coordinator, Substance Abuse and 

Mental Health Services Administration, 

5600 Fishers Lane, Rockville, MD 

20857, Telephone (240) 276–1898; 

Email: Dorrine.Gross@samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Funding Opportunity Title: FY 2024 

Projects for Assistance in Transition 

from Homelessness, SM–24–F2. 

Assistance Listing Number: 93.150. 

Authority: The PATH program was 

originally authorized as section 521 of 

the Public Health Service Act (42 U.S.C. 

290cc-21) established by the Stewart B. 

McKinney Homeless Assistance 

Amendments Act of 1990 (Pub. L. 101– 

645) and was most recently reauthorized through the Consolidated 

Appropriations Act, 2023 (Pub. L. 117– 

328). 

Justification: Eligibility for this 

supplemental funding is limited to the 

56 PATH recipients awarded under 

funding announcement SM–24–F2 as 

they are currently providing services as 

defined in statute. 

This is not a formal request for 

application. Assistance will only be 

provided to the 56 PATH recipients 

based on the receipt of a statement 

requesting the funds, including a 

description of how the PATH recipient 

intends to use the supplemental funds. 

Dated: September 3, 2024. 

Savannah Kidd, 

Supervisory Public Health Analyst. 

[FR Doc. 2024–20183 Filed 9–6–24; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID FEMA–2007–0008] 

National Advisory Council; Meeting 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security. 

ACTION: Notice of open Federal advisory 

committee meeting. 

SUMMARY: The Federal Emergency 

Management Agency’s National 

Advisory Council (NAC) will meet on 

Sept. 25–26, 2024 to publicly consider, 

deliberate and vote upon draft 

recommendations developed by NAC 

subcommittees in 2024. This meeting 

will be open to the public through 

virtual means and, space permitting, to 

in-person attendance requests. 

DATES: The NAC plans to meet and 

invite the public to watch and 

participate by virtual means from noon 

to 4:15 p.m. Eastern Time (ET) on 

Wednesday, Sept. 25; and from 1 p.m. 

to 5:15 p.m. ET on Thursday, Sept. 26. 

The meeting may pause for breaks or 

continue past the scheduled end time or 

may end early any day that the NAC has 

completed its business. 

ADDRESSES: Anyone who wishes to 

participate virtually must register with 

FEMA in advance by providing their 

name, official title, organization, 

telephone number, and email address to 

the person listed in the FOR FURTHER

INFORMATION CONTACT section below by 

3 p.m. ET on Friday, Sept. 20. Anyone 

willing to meet the access requirements 

of the secure facility at 1015 Half St. SE, 

Washington, DC 20003 at which this 

meeting will be held may request to be 

considered for in-person participation, 

space permitting, if the request is 

received by 3 p.m. on Wednesday, Sept. 


ddrumheller on DSK120RN23PROD with NOTICES1